Shanghai Pharmaceuticals Holding Co Ltd (601607) — Cash Flow-to-Debt Ratio
Shanghai Pharmaceuticals Holding Co Ltd (601607) has a Cash Flow-to-Debt Ratio of 0.01x as of September 2025, meaning its operating cash flow of CN¥1.56 Billion could theoretically repay 0% of its total liabilities (CN¥147.12 Billion) in one year. See 601607 financial flexibility score to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Shanghai Pharmaceuticals Holding Co Ltd Cash Flow-to-Debt Ratio (1998–2025)
Historical debt coverage capacity for Shanghai Pharmaceuticals Holding Co Ltd across 28 annual periods. For the full cash flow conversion analysis, see 601607 cash generation efficiency.
Annual Cash Flow-to-Debt Ratio for Shanghai Pharmaceuticals Holding Co Ltd (1998–2025)
Year-by-year debt coverage analysis for Shanghai Pharmaceuticals Holding Co Ltd. Check earnings quality score of Shanghai Pharmaceuticals Holding Co Ltd to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.04x | CN¥6.15 Billion | CN¥143.36 Billion | ▲ +1.3% |
| 2024 | 0.04x | CN¥5.83 Billion | CN¥137.47 Billion | ▲ +6.7% |
| 2023 | 0.04x | CN¥5.23 Billion | CN¥131.65 Billion | ▲ +0.6% |
| 2022 | 0.04x | CN¥4.74 Billion | CN¥120.13 Billion | ▼ -18.6% |
| 2021 | 0.05x | CN¥5.06 Billion | CN¥104.37 Billion | ▼ -33.1% |
| 2020 | 0.07x | CN¥6.84 Billion | CN¥94.44 Billion | ▲ +5.5% |
| 2019 | 0.07x | CN¥6.02 Billion | CN¥87.64 Billion | ▲ +76.3% |
| 2018 | 0.04x | CN¥3.14 Billion | CN¥80.45 Billion | ▼ -19.6% |
| 2017 | 0.05x | CN¥2.65 Billion | CN¥54.67 Billion | ▲ +14.3% |
| 2016 | 0.04x | CN¥1.95 Billion | CN¥45.91 Billion | ▲ +27.4% |
| 2015 | 0.03x | CN¥1.35 Billion | CN¥40.54 Billion | ▼ -17.2% |
| 2014 | 0.04x | CN¥1.34 Billion | CN¥33.24 Billion | ▲ +12.7% |
| 2013 | 0.04x | CN¥973.45 Million | CN¥27.31 Billion | ▼ -27.6% |
| 2012 | 0.05x | CN¥1.15 Billion | CN¥23.37 Billion | ▼ -39.7% |
| 2011 | 0.08x | CN¥1.77 Billion | CN¥21.69 Billion | ▼ -21.1% |
| 2010 | 0.10x | CN¥1.69 Billion | CN¥16.28 Billion | ▼ -1.2% |
| 2009 | 0.10x | CN¥664.13 Million | CN¥6.33 Billion | ▲ +107.9% |
| 2008 | 0.05x | CN¥285.68 Million | CN¥5.67 Billion | ▼ -46.7% |
| 2007 | 0.09x | CN¥488.94 Million | CN¥5.17 Billion | ▼ -25.2% |
| 2006 | 0.13x | CN¥583.11 Million | CN¥4.61 Billion | ▲ +656.9% |
| 2005 | 0.02x | CN¥73.00 Million | CN¥4.37 Billion | ▲ +19.3% |
| 2004 | 0.01x | CN¥61.66 Million | CN¥4.40 Billion | ▲ +11546.7% |
| 2003 | 0.00x | CN¥484.27K | CN¥4.03 Billion | ▼ -99.6% |
| 2002 | 0.03x | CN¥100.84 Million | CN¥3.40 Billion | ▲ +11.6% |
| 2001 | 0.03x | CN¥65.73 Million | CN¥2.47 Billion | ▼ -53.7% |
| 2000 | 0.06x | CN¥146.22 Million | CN¥2.55 Billion | ▼ -23.2% |
| 1999 | 0.07x | CN¥164.67 Million | CN¥2.21 Billion | ▲ +150.0% |
| 1998 | -0.15x | CN¥-283.14 Million | CN¥1.90 Billion | — |